Stratos Wealth Partners, Ltd. Cara Therapeutics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$12.45 - $23.47 $821 - $1,549	-66 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$17.57 - $23.95 $1,159 - $1,580	66 New	66 $2,000
Q2 2018 Aug 13, 2018	SELL	$11.6 - $19.27 $765 - $1,271	-66 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$11.77 - $16.08 $776 - $1,061	66 New	66 $1,000

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.